Clinical trial

Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis

NCT06301373

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Methotrexate Combined With Tofacitinib Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Methotrexate Normalized identity: methotrexateView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-09-01

PhaseNA

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

Methotrexate Combined With TofacitinibDRUG

MethotrexateDRUG · verified · RxNorm: methotrexate

Sponsors & collaborators

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universitylead sponsor

Mapped research locations

GuangzhouGuangdong, China2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06301373 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.